Basic Information
RNALocate ID: | RLID:11001333 |
RNA Symbol: | hsa-miR-30c-5p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-30c |
RNA ID: | miRBase:MIMAT0000244 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001571 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001572 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001573 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001574 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001575 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001576 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001577 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001578 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001579 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:01001580 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11001327 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
RLID:11001328 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11001329 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001330 | Exosome | Brain tissue | 23382797 |
RLID:11001331 | Exosome | Plasma | 23663360 |
RLID:11001332 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID-D:11000042 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000311 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-30c-5p | Splenic marginal zone lymphoma | MNDR-E-MI-37242 |
MNDR | hsa-miR-30c-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-37243 |
MNDR | hsa-miR-30c-5p | Glomerulosclerosis | MNDR-E-MI-37244 |
MNDR | hsa-miR-30c-5p | Oral squamous cell carcinoma | MNDR-E-MI-37245 |
MNDR | hsa-miR-30c-5p | Large cell neuroendocrine cancer | MNDR-E-MI-37246 |
MNDR | hsa-miR-30c-5p | Medulloblastoma | MNDR-E-MI-37247 |
MNDR | hsa-miR-30c-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-37248 |
MNDR | hsa-miR-30c-5p | Lymphoma | MNDR-E-MI-37249 |
MNDR | hsa-miR-30c-5p | Lymphoma non-hodgkin | MNDR-E-MI-37250 |
MNDR | hsa-miR-30c-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-37251 |
MNDR | hsa-miR-30c-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-37252 |
MNDR | hsa-miR-30c-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-37253 |
MNDR | hsa-miR-30c-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-37254 |
MNDR | hsa-miR-30c-5p | Her2-receptor positive breast cancer | MNDR-E-MI-37255 |
MNDR | hsa-miR-30c-5p | Niemann-pick disease type c | MNDR-E-MI-37256 |
MNDR | hsa-miR-30c-5p | Miyoshi myopathy | MNDR-E-MI-37257 |
MNDR | hsa-miR-30c-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-37258 |
MNDR | hsa-miR-30c-5p | Dermatomyositis | MNDR-E-MI-37259 |
MNDR | hsa-miR-30c-5p | Prostate cancer | MNDR-E-MI-37260 |
MNDR | hsa-miR-30c-5p | Gastric cancer | MNDR-E-MI-37261 |
MNDR | hsa-miR-30c-5p | Alzheimer disease | MNDR-E-MI-37262 |
MNDR | hsa-miR-30c-5p | Intracranial aneurysm | MNDR-E-MI-37263 |
MNDR | hsa-miR-30c-5p | Bladder cancer | MNDR-E-MI-37264 |
MNDR | hsa-miR-30c-5p | Esophageal carcinoma | MNDR-E-MI-37265 |
MNDR | hsa-miR-30c-5p | Dysautonomia familial | MNDR-E-MI-37266 |
MNDR | hsa-miR-30c-5p | Distal muscular dystrophy | MNDR-E-MI-37267 |
MNDR | hsa-miR-30c-5p | Duchenne muscular dystrophy | MNDR-E-MI-37268 |
MNDR | hsa-miR-30c-5p | Head and neck cancer | MNDR-E-MI-37269 |
MNDR | hsa-miR-30c-5p | Huntington disease | MNDR-E-MI-37270 |
MNDR | hsa-miR-30c-5p | Chorea | MNDR-E-MI-37271 |
MNDR | hsa-miR-30c-5p | Cardiovascular disease | MNDR-E-MI-37272 |
MNDR | hsa-miR-30c-5p | Carotid stenosis | MNDR-E-MI-37273 |
MNDR | hsa-miR-30c-5p | Lung cancer | MNDR-E-MI-37274 |
MNDR | hsa-miR-30c-5p | Endometrial cancer | MNDR-E-MI-37275 |
MNDR | hsa-miR-30c-5p | Down syndrome | MNDR-E-MI-37276 |
MNDR | hsa-miR-30c-5p | Parkinson disease | MNDR-E-MI-37277 |
MNDR | hsa-miR-30c-5p | Niemann-pick disease | MNDR-E-MI-37278 |
MNDR | hsa-miR-30c-5p | Breast cancer | MNDR-E-MI-37279 |
MNDR | hsa-miR-30c-5p | Pancreatic cancer | MNDR-E-MI-37280 |
MNDR | hsa-miR-30c-5p | Melanoma | MNDR-E-MI-37281 |
MNDR | hsa-miR-30c-5p | Rectum adenocarcinoma | MNDR-E-MI-37282 |
MNDR | hsa-miR-30c-5p | Nephroblastoma | MNDR-E-MI-37283 |
MNDR | hsa-miR-30c-5p | Colon cancer | MNDR-E-MI-37284 |
MNDR | hsa-miR-30c-5p | Colon adenocarcinoma | MNDR-E-MI-37285 |
MNDR | hsa-miR-30c-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-37286 |
MNDR | hsa-miR-30c-5p | Familial ovarian cancer | MNDR-E-MI-37287 |
MNDR | hsa-miR-30c-5p | Prostate adenocarcinoma | MNDR-E-MI-37288 |
MNDR | hsa-miR-30c-5p | Cerebellar disease | MNDR-E-MI-37289 |
MNDR | hsa-miR-30c-5p | Carcinoma ductal breast | MNDR-E-MI-37290 |
MNDR | hsa-miR-30c-5p | Glioblastoma | MNDR-E-MI-37291 |
MNDR | hsa-miR-30c-5p | Astrocytoma | MNDR-E-MI-37292 |
MNDR | hsa-miR-30c-5p | Glioma | MNDR-E-MI-37293 |
MNDR | hsa-miR-30c-5p | Central nervous system lymphoma | MNDR-E-MI-37294 |
MNDR | hsa-miR-30c-5p | Chordoma | MNDR-E-MI-37295 |
MNDR | hsa-miR-30c-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-37296 |
MNDR | hsa-miR-30c-5p | Osteosarcoma | MNDR-E-MI-37297 |
MNDR | hsa-miR-30c-5p | Inclusion body myositis | MNDR-E-MI-37298 |
MNDR | hsa-miR-30c-5p | Meningioma | MNDR-E-MI-37299 |
MNDR | hsa-miR-30c-5p | Liver cancer | MNDR-E-MI-37300 |
MNDR | hsa-miR-30c-5p | Gastric adenocarcinoma | MNDR-E-MI-37301 |
MNDR | hsa-miR-30c-5p | Cervical squamous cell carcinoma | MNDR-E-MI-37302 |
MNDR | hsa-miR-30c-5p | Lung squamous cell carcinoma | MNDR-E-MI-37303 |
MNDR | hsa-miR-30c-5p | Carcinoma lung non-small-cell | MNDR-E-MI-37304 |
MNDR | hsa-miR-30c-5p | Lung adenocarcinoma | MNDR-E-MI-37305 |
MNDR | hsa-miR-30c-5p | Thyroid carcinoma | MNDR-E-MI-37306 |
MNDR | hsa-miR-30c-5p | Ovarian carcinoma | MNDR-E-MI-37307 |
MNDR | hsa-miR-30c-5p | Bladder urothelial carcinoma | MNDR-E-MI-37308 |
MNDR | hsa-miR-30c-5p | Liver disease | MNDR-E-MI-37309 |
MNDR | hsa-miR-30c-5p | Carcinoma renal cell | MNDR-E-MI-37310 |
MNDR | hsa-miR-30c-5p | Clear cell renal cell carcinoma | MNDR-E-MI-37311 |
MNDR | hsa-miR-30c-5p | Large cell carcinoma | MNDR-E-MI-37312 |
MNDR | hsa-miR-30c-5p | Biliary tract cancer | MNDR-E-MI-37313 |
MNDR | hsa-miR-30c-5p | Cholangiocarcinoma | MNDR-E-MI-37314 |
MNDR | hsa-miR-30c-5p | Esophageal cancer | MNDR-E-MI-37315 |
MNDR | hsa-miR-30c-5p | Liver cirrhosis | MNDR-E-MI-37316 |
MNDR | hsa-miR-30c-5p | Lung small cell carcinoma | MNDR-E-MI-37317 |
MNDR | hsa-miR-30c-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-37318 |
MNDR | hsa-miR-30c-5p | Heart failure | MNDR-E-MI-37319 |
MNDR | hsa-miR-30c-5p | Aortic valve disease | MNDR-E-MI-37320 |
MNDR | hsa-miR-30c-5p | Encephalomyelitis | MNDR-E-MI-37321 |
MNDR | hsa-miR-30c-5p | Breast invasive carcinoma | MNDR-E-MI-37322 |
MNDR | hsa-miR-30c-5p | Early hepatocellular carcinoma | MNDR-E-MI-37323 |
MNDR | hsa-miR-30c-5p | Familiar ovarian carcinoma | MNDR-E-MI-37324 |
MNDR | hsa-miR-30c-5p | B-cell lymphoma | MNDR-E-MI-37325 |
MNDR | hsa-miR-30c-5p | Rheumatoid arthritis | MNDR-E-MI-37326 |
MNDR | hsa-miR-30c-5p | T-cell leukemia | MNDR-E-MI-37327 |
MNDR | hsa-miR-30c-5p | Retinoblastoma | MNDR-E-MI-37328 |
MNDR | hsa-miR-30c-5p | Influenza | MNDR-E-MI-37329 |
MNDR | hsa-miR-30c-5p | Hodgkin lymphoma | MNDR-E-MI-37330 |
MNDR | hsa-miR-30c-5p | Burkitt lymphoma | MNDR-E-MI-37331 |
MNDR | hsa-miR-30c-5p | Tonsil cancer | MNDR-E-MI-37332 |
MNDR | hsa-miR-30c-5p | Psoriasis | MNDR-E-MI-37333 |
MNDR | hsa-miR-30c-5p | Colorectal cancer | MNDR-E-MI-37334 |
MNDR | hsa-miR-30c-5p | Nasopharynx carcinoma | MNDR-E-MI-37335 |
MNDR | hsa-miR-30c-5p | Multiple myeloma | MNDR-E-MI-37336 |
MNDR | hsa-miR-30c-5p | Acute lymphocytic leukemia | MNDR-E-MI-37337 |
MNDR | hsa-miR-30c-5p | Diabetic nephropathies | MNDR-E-MI-37338 |
MNDR | hsa-miR-30c-5p | Ependymoma | MNDR-E-MI-37339 |
MNDR | hsa-miR-30c-5p | Cardiac hypertrophy | MNDR-E-MI-37340 |
MNDR | hsa-miR-30c-5p | Nasopharyngeal cancer | MNDR-E-MI-37341 |
MNDR | hsa-miR-30c-5p | Prostatic neoplasms | MNDR-E-MI-37342 |
MNDR | hsa-miR-30c-5p | Sclerosis | MNDR-E-MI-37343 |
MNDR | hsa-miR-30c-5p | Sleep deprivation | MNDR-E-MI-37344 |
MNDR | hsa-miR-30c-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-37345 |
MNDR | hsa-miR-30c-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-37346 |
MNDR | hsa-miR-30c-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37347 |
MNDR | hsa-miR-30c-5p | Stroke lacunar | MNDR-E-MI-37348 |
MNDR | hsa-miR-30c-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-37349 |
MNDR | hsa-miR-30c-5p | Breast cancer her3+ negative | MNDR-E-MI-37350 |
MNDR | hsa-miR-30c-5p | Cerebellar neurodegeneration | MNDR-E-MI-37351 |
MNDR | hsa-miR-30c-5p | Duke C | MNDR-E-MI-37352 |
MNDR | hsa-miR-30c-5p | High grade dysplastic nodule | MNDR-E-MI-37353 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AC254633.1 | Homo sapiens | RR00032112 |
TOP